(Q34989464)

5 August 2017

1 reference

title

Similarities between Alzheimer's disease and vascular dementia (English)

1 reference

5 August 2017

0 references

0 references

Raj Kalaria

1

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Journal of the Neurological Sciences

5 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 August 2017

volume

203-204

1 reference

5 August 2017

page(s)

29-34

1 reference

Prevalence and outcomes of vascular cognitive impairment

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Epidemiology of vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Increased sympathetic and decreased parasympathetic cardiac innervation in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Risk of left ventricular dysfunction in patients with probable Alzheimer's disease with APOE*4 allele.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Arteriosclerosis, apolipoprotein E, and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Comparison of pathological diagnostic criteria for Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Cognitive impairment and risk of stroke in the older population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Cognitive impairment and mortality in a cohort of elderly people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Neuropathological assessment of the lesions of significance in vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Changes in nicotinic acetylcholine receptor subunit mRNAs and nicotinic binding in spontaneously hypertensive stroke prone rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Amyloid beta-protein precursor deposition in rat hippocampus lesioned by ibotenic acid injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Nicotine modulates the neurotoxic effect of beta-amyloid protein(25-35)) in hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Perspectives in the treatment of vascular dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Nicotinic acetylcholine involvement in cognitive function in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Current status and new developments with galantamine in the treatment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900256-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00256-3

1 reference

5 August 2017

1 reference